Alzheimer's disease drugs: an application of the hormetic dose-response model (Q37196488)

18 August 2017

1 reference

title

Alzheimer's disease drugs: an application of the hormetic dose-response model (English)

1 reference

18 August 2017

0 references

Edward J Calabrese

1

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

Critical Reviews in Toxicology

18 August 2017

published in

1 reference

18 August 2017

volume

38

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

419-451

1 reference

The effects of physostigmine and scopolamine on recognition memory in monkeys

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

The synthetic enantiomer of pregnenolone sulfate is very active on memory in rats and mice, even more so than its physiological neurosteroid counterpart: distinct mechanisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Physostigmine and its effect on six patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Memory facilitation with posttrial injection of oxotremorine and physostigmine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Arecoline via miniosmotic pump improves AF64A-impaired radial maze performance in rats: a possible model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Physostigmine and Recent Memory: Effects in Young and Aged Nonhuman Primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Short-term memory in the rhesus monkey: Effects of dopamine blockade via acute haloperidol administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: Effects of concurrent administration of physostigmine and methylphenidate with scopolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Memory deficits in aged cebus monkeys and facilitation with central cholinomimetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Aging in the Rhesus Monkey: Debilitating Effects on Short-term Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

The role of platelet activating factor in prion and amyloid-beta neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Ginkgolide B inhibits the neurotoxicity of prions or amyloid-beta1-42

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

The effects of ACTH, adrenalectomy and dexamethasone on the acquisition of an avoidance response in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

The effects of physostigmine on memory and auditory P300 in Alzheimer-type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Cognition-activating properties of 3-(aryloxy)pyridines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Toxicology rethinks its central belief

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

The frequency of U-shaped dose responses in the toxicological literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Oral administration of chronic physostigmine does not improve cognitive or mnesic performances in Alzheimer's presenile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease. Eptastigmine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Brain Acetylcholine and Habituation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Strain-dependent effects of cocaine on memory storage improvement induced by post-training physostigmine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

An experimental test of the role of postsynaptic calcium levels in determining synaptic strength using perirhinal cortex of rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Effects of physotigmine on the acquisition of a position discrimination in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Release of acetylcholine at voluntary motor nerve endings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Physostigmine: effects on cognition and affect in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Physostigmine: Improvement of Long-Term Memory Processes in Normal Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

The cholinergic synapse and the site of memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Inverted-U relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Memory and cognitive function in man: Does the cholinergic system have a specific role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Human memory and the cholinergic system. A relationship to aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Memory and cognitive function in the elderly. A preliminary trial of physostigmine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Enhancement of passive avoidance learning through small doses of intra-amygdaloid physostigmine in the young rat. Its relation to the development of acetylcholinesterase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Long-term choline treatment of memory-impaired elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Cholecystokinin receptors mediate enhanced memory retention produced by feeding and gastrointestinal peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Cholinergic receptor interactions and their effects on long-term memory processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Memory enhancement: supra-additive effect of subcutaneous cholinergic drug combinations in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Modulation of memory processing by neuropeptide Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Modulation of memory processing by cholecystokinin: dependence on the vagus nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Dehydroepiandrosterone and its sulfate enhance memory retention in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Modulation of memory processing by neuropeptide Y varies with brain injection site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Cholinesterase inhibitors stabilize Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Posttraining brain norepinephrine concentrations: correlation with retention performance of avoidance training and with peripheral epinephrine modulation of memory processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Effects of posttrial hormone injections on memory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Enhancement and impairment of memory processes with post-trial injections of adrenocorticotrophic hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Facilitation of time-dependent memory processes with posttrial epinephrine injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Modulation of long-term potentiation by peripherally administered amphetamine and epinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Retention deficit for avoidance training in hypophysectomized rats: Time-dependent enhancement of retention performance with post-training ACTH injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Appetitive acquisition and extinction effects with exogenous ACTH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Post-training vasopressin injections may facilitate or delay shuttle-box avoidance extinction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Cholinergic modulation of memory in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Pharmacological alleviation of cholinergic lesion induced memory deficits in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Binding of platelet-activating factor to platelets of Alzheimer's disease and multiinfarct dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Low-dose mecamylamine improves learning of rats in the radial-arm maze repeated acquisition procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Physostigmine improves ECT-induced memory disturbances

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Brain cholinergic dysfunction and memory in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

A mechanism for the Hebb and the anti-Hebb processes underlying learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Hormetic influence of glucocorticoids on human memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Physostigmine improves water maze performance following nucleus basalis magnocellularis lesions in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Long-term potentiation and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Differential effects of physostigmine and pilocarpine on the spatial memory deficits produced by two septo-hippocampal deafferentations in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Dehydroepiandrosterone is an anxiolytic in mice on the plus maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Efficacy of physostigmine as a pretreatment for organophosphate poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Clinical studies of the cholinergic deficit in Alzheimer's disease. II. Psychopharmacologic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Effect of Physostigmine on Constructional and Memory Tasks in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Learning and memory deficits after lesions of the nucleus basalis magnocellularis: reversal by physostigmine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Release of amyloid beta-protein precursor derivatives by electrical depolarization of rat hippocampal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Effect of huperzine A on working memory in reserpine- or yohimbine-treated monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Effects of physostigmine and lecithin on memory in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Memory Enhancement After Physostigmine Treatment in the Amnesic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Depression of two-way avoidance learning and enhancement of passive avoidance learning by small doses of physostigmine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Enhancement and disruption of retention performance by ACTH in a choice task

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Effects of ACTH on conditioned suppression: a time and strength of conditioning analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Physostigmine effects in Alzheimer's disease: relationship to dementia severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Human Serial Learning: Enhancement with Arecholine and Choline Impairment with Scopolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Cholinergic improvement of a naturally-occurring memory deficit in the young rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Memory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Choline-esterase. An enzyme present in the blood-serum of the horse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Long-term administration of oral physostigmine in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Effects of oral physostigmine in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Attenuation of scopolamine-induced amnesia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Biphasic effect of tacrine on acetylcholine release in rat brain via M1 and M2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Water-maze learning and effects of cholinergic drugs in mouse strains with high and low hippocampal pyramidal cell counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Oral physostigmine and lecithin improve memory in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Lesion with the neurotoxin AF64A alters hippocampal cholinergic receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Cocaine-induced modulation of long-term potentiation in the CA1 region of rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Neurosteroids in learning and memory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Adrenocortical influences on free-operant avoidance behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

The protective effect of ganstigmine against amyloid beta 25-35 neurotoxicity on chicken cortical neurons is independent from the cholinesterase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Effect of Huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Hormesis: from marginalization to mainstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

TREATMENT OF MYASTHENIA GRAVIS WITH PHYSOSTIGMINE

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Oral physostigmine treatment of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Pharmacological profile of PMS777, a new AChE inhibitor with PAF antagonistic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Tacrine in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408440802003991

10.1080/10408440802003991

21 January 2018

Identifiers

DOI

1 reference

release_5qqm5tkanjcxbe2zz2d5bwux5e

18 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5qqm5tkanjcxbe2zz2d5bwux5e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference